Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$14.08 +0.06 (+0.43%)
As of: Sep 4, 2026 · 3:59 PM EDT

Enanta Pharmaceuticals (ENTA) Prepaid Assets (2012 - 2026)

Enanta Pharmaceuticals' (ENTA) quarterly Prepaid Assets came in at $6.8 million in Q1 2026, down 23.11% YoY from $8.9 million in Q1 2025, and up 56.84% on a QoQ basis from $4.3 million in Q4 2025.

Analysis

Enanta Pharmaceuticals (ENTA) Prepaid Assets (2012 - 2026) Analysis & Trends

Enanta Pharmaceuticals (ENTA) has 15 years of Prepaid Assets data on file, last reported at $6.8 million in Q1 2026.

  • Quarterly Prepaid Assets fell 23.11% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (down 23.11% YoY) and the FY2025 annual result came in at $8.6 million, down 30.8% from the prior year.
  • Prepaid Assets advanced to $6.8 million in Q1 2026, from $4.3 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $17.9 million in Q4 2022 to a low of $4.3 million in Q4 2025.
  • A 5-year average of $12.0 million and a median of $12.4 million in 2024 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets soared 55.97% — and 2025, when it plunged 59.36%.
  • Tracing ENTA's Prepaid Assets over 5 years: stood at $17.9 million in 2022, then dropped by 26.2% to $13.2 million in 2023, then dropped by 19.34% to $10.7 million in 2024, then slumped by 59.36% to $4.3 million in 2025, then soared by 56.84% to $6.8 million in 2026.
  • The last three Prepaid Assets figures came in at $6.8 million (Q1 2026), $4.3 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Enanta Pharmaceuticals 409.30 Mn 219.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.58 Mn
Mar 31, 2026 6.81 Mn
Dec 31, 2025 4.34 Mn
Sep 30, 2025 8.59 Mn
Jun 30, 2025 10.24 Mn
Mar 31, 2025 8.86 Mn
Dec 31, 2024 10.68 Mn
Sep 30, 2024 12.41 Mn
Jun 30, 2024 15.26 Mn
Mar 31, 2024 10.93 Mn
Dec 31, 2023 13.25 Mn
Sep 30, 2023 13.26 Mn
Jun 30, 2023 17.07 Mn
Mar 31, 2023 14.48 Mn
Dec 31, 2022 17.95 Mn
Sep 30, 2022 13.45 Mn
Jun 30, 2022 11.54 Mn
Mar 31, 2022 14.08 Mn
Dec 31, 2021 11.51 Mn
Sep 30, 2021 14.19 Mn